by Vora Corporate Finance | Apr 16, 2025 | Insights, Private Equity & IPO
Transaction: DCDC Kidney Care, which operates dialysis centers under the DCDC Kidney Care brand, has secured an investment of ₹150 crore from Singapore-based ABC Impact, the Asia-focused impact investor backed by Temasek. About DCDC Kidney Care: Founded in 2009, DCDC...
by Vora Corporate Finance | Apr 16, 2025 | Insights, Merger & Acquisitions
Transaction: Zydus Lifesciences Limited has entered into exclusive negotiations to purchase a controlling stake of 85.6% in France-based Amplitude Surgical SA for a deal valued at €256.8 million (over ₹2,400 crore). Zydus will file a mandatory cash tender offer for...
by Vora Corporate Finance | Apr 16, 2025 | Insights
There were No main board IPOs in March 2025 against 04 main board IPOs in February 2025. There were 07 SME IPOs in March 2025 as against 06 SME IPOs in February 2025. After heightened activity in 2024, there has been a slowdown in new listings, with no main-board...
by Vora Corporate Finance | Mar 27, 2025 | Insights, Merger & Acquisitions
Transaction: Fortis Healthcare Limited is set to acquire the 228-bed Shrimann Superspeciality Hospital in Jalandhar for approximately $53m (INR 462 crores) through a slump sale. The acquisition includes the entire business operations, hospital building, land, and an...
by Vora Corporate Finance | Mar 27, 2025 | Insights
There were 04 main board IPOs in February 2025 of Quality Power Electrical Equipments Limited, Hexaware Technologies Limited, AJAX Engineering Limited, and Dr. Agarwal’s Health Care Limited against 06 main board IPOs in January 2025. There were 06 SME IPOs in...
